Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target
Philis-Tsimikas A, Asong M, Franek E, et al.
Lancet Diabetes Endocrinol. 2023;S2213-8587(23)00093-1.
Leggi


